Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons - PubMed (original) (raw)
. 2015 Sep 21;25(18):2349-60.
doi: 10.1016/j.cub.2015.07.050. Epub 2015 Aug 27.
Affiliations
- PMID: 26320949
- DOI: 10.1016/j.cub.2015.07.050
Free article
Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons
Consiglia Pacelli et al. Curr Biol. 2015.
Free article
Abstract
Although the mechanisms underlying the loss of neurons in Parkinson's disease are not well understood, impaired mitochondrial function and pathological protein aggregation are suspected as playing a major role. Why DA (dopamine) neurons and a select small subset of brain nuclei are particularly vulnerable to such ubiquitous cellular dysfunctions is presently one of the key unanswered questions in Parkinson's disease research. One intriguing hypothesis is that their heightened vulnerability is a consequence of their elevated bioenergetic requirements. Here, we show for the first time that vulnerable nigral DA neurons differ from less vulnerable DA neurons such as those of the VTA (ventral tegmental area) by having a higher basal rate of mitochondrial OXPHOS (oxidative phosphorylation), a smaller reserve capacity, a higher density of axonal mitochondria, an elevated level of basal oxidative stress, and a considerably more complex axonal arborization. Furthermore, we demonstrate that reducing axonal arborization by acting on axon guidance pathways with Semaphorin 7A reduces in parallel the basal rate of mitochondrial OXPHOS and the vulnerability of nigral DA neurons to the neurotoxic agents MPP(+) (1-methyl-4-phenylpyridinium) and rotenone. Blocking L-type calcium channels with isradipine was protective against MPP(+) but not rotenone. Our data provide the most direct demonstration to date in favor of the hypothesis that the heightened vulnerability of nigral DA neurons in Parkinson's disease is directly due to their particular bioenergetic and morphological characteristics.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Comment in
- Neurodegeneration: The Size Takes It All.
Franco-Iborra S, Perier C. Franco-Iborra S, et al. Curr Biol. 2015 Sep 21;25(18):R797-800. doi: 10.1016/j.cub.2015.07.062. Curr Biol. 2015. PMID: 26394101
Similar articles
- Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.
Giguère N, Delignat-Lavaud B, Herborg F, Voisin A, Li Y, Jacquemet V, Anand-Srivastava M, Gether U, Giros B, Trudeau LÉ. Giguère N, et al. PLoS Genet. 2019 Aug 26;15(8):e1008352. doi: 10.1371/journal.pgen.1008352. eCollection 2019 Aug. PLoS Genet. 2019. PMID: 31449520 Free PMC article. - Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
Masi A, Narducci R, Resta F, Carbone C, Kobayashi K, Mannaioni G. Masi A, et al. Eur J Neurosci. 2015 Nov;42(9):2699-706. doi: 10.1111/ejn.13066. Epub 2015 Oct 19. Eur J Neurosci. 2015. PMID: 26354486 - Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
Giguère N, Pacelli C, Saumure C, Bourque MJ, Matheoud D, Levesque D, Slack RS, Park DS, Trudeau LÉ. Giguère N, et al. J Biol Chem. 2018 Jun 22;293(25):9580-9593. doi: 10.1074/jbc.RA117.000499. Epub 2018 Apr 26. J Biol Chem. 2018. PMID: 29700116 Free PMC article. - Dopaminergic neuron metabolism: relevance for understanding Parkinson's disease.
Flores-Ponce X, Velasco I. Flores-Ponce X, et al. Metabolomics. 2024 Oct 13;20(6):116. doi: 10.1007/s11306-024-02181-4. Metabolomics. 2024. PMID: 39397188 Free PMC article. Review. - Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.
Haddad D, Nakamura K. Haddad D, et al. FEBS Lett. 2015 Dec 21;589(24 Pt A):3702-13. doi: 10.1016/j.febslet.2015.10.021. Epub 2015 Oct 23. FEBS Lett. 2015. PMID: 26526613 Free PMC article. Review.
Cited by
- Small Molecules, α-Synuclein Pathology, and the Search for Effective Treatments in Parkinson's Disease.
Sechi GP, Sechi MM. Sechi GP, et al. Int J Mol Sci. 2024 Oct 18;25(20):11198. doi: 10.3390/ijms252011198. Int J Mol Sci. 2024. PMID: 39456980 Free PMC article. Review. - Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.
Henrich MT, Oertel WH, Surmeier DJ, Geibl FF. Henrich MT, et al. Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7. Mol Neurodegener. 2023. PMID: 37951933 Free PMC article. Review. - Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson's Patients, Using In Vivo 31P MRS-Based Metabolic Imaging at 7T.
Zhu XH, Lee BY, Tuite P, Coles L, Sathe AG, Chen C, Cloyd J, Low WC, Steer CJ, Chen W. Zhu XH, et al. Metabolites. 2021 Mar 1;11(3):145. doi: 10.3390/metabo11030145. Metabolites. 2021. PMID: 33804401 Free PMC article. - Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
Liang Y, Cui L, Gao J, Zhu M, Zhang Y, Zhang HL. Liang Y, et al. Mol Neurobiol. 2021 Aug;58(8):3745-3758. doi: 10.1007/s12035-021-02375-0. Epub 2021 Apr 6. Mol Neurobiol. 2021. PMID: 33825149 Free PMC article. Review. - Functional Consequences of Calcium-Dependent Synapse-to-Nucleus Communication: Focus on Transcription-Dependent Metabolic Plasticity.
Hagenston AM, Bading H, Bas-Orth C. Hagenston AM, et al. Cold Spring Harb Perspect Biol. 2020 Apr 1;12(4):a035287. doi: 10.1101/cshperspect.a035287. Cold Spring Harb Perspect Biol. 2020. PMID: 31570333 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous